Germany renews DEHP debate
This article was originally published in Clinica
Executive Summary
A German expert hearing on the use of and risks associated with the PVC softener DEHP in medical devices has unanimously agreed that steps should be taken to reduce human exposure to the compound. Delegates at the meeting, in Bonn on January 18, said that use in high risk groups, ie those who have not yet undergone sexual development, should be minimised.